| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0007200 | Exon-Exon | chr10:31644073-31791437 | chr10:31355144-31502509 | 55 nt | 0.3455 |
| hsa_ZEB1_0005400 | Intron-Exon-Intron | chr10:31644073-31813041 | chr10:31355144-31524113 | 250 nt | 0.2960 |
| hsa_ZEB1_0005500 | Intron-Exon | chr10:31644073-31816045 | chr10:31355144-31527117 | 250 nt | 0.3400 |
| hsa_ZEB1_0007900 | Exon-Intron | chr10:31644076-31650925 | chr10:31355147-31361996 | 46 nt | 0.3478 |
| hsa_ZEB1_0008000 | Exon-Intron | chr10:31644076-31655054 | chr10:31355147-31366125 | 153 nt | 0.4510 |
| hsa_ZEB1_0008100 | Exon-Intron | chr10:31644076-31662102 | chr10:31355147-31373173 | 202 nt | 0.3713 |
| hsa_ZEB1_0008200 | Exon-Intron | chr10:31644076-31663893 | chr10:31355147-31374964 | 220 nt | 0.3591 |
| hsa_ZEB1_0008300 | Exon-Intron | chr10:31644076-31677801 | chr10:31355147-31388872 | 46 nt | 0.3478 |
| hsa_ZEB1_0008400 | Exon-Intron | chr10:31644076-31678589 | chr10:31355147-31389660 | 56 nt | 0.4107 |
| hsa_ZEB1_0008500 | Exon-Intron | chr10:31644076-31678624 | chr10:31355147-31389695 | 345 nt | 0.4029 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].